| Dr Edward Glenn Browning, DO | |
|
1108 E Patterson St, Suite 5, Kirksville, MO 63501-4002 | |
| (660) 627-1229 | |
| (660) 665-5313 |
| Full Name | Dr Edward Glenn Browning |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 50 Years |
| Location | 1108 E Patterson St, Kirksville, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821088899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | R7214 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Springfield Hospital | Springfield, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Springfield Hospital Inc. | 6507760337 | 30 |
News Archive
Researchers report that the addition of Achilles tendon lengthening to procedures for managing diabetic forefoot and midfoot ulceration seems warranted.
Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma.
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.
"Although we're several days into sequestration, details about the full impact of funding cuts are still hazy," Kim Lufkin, communications officer of the Global Health Technologies Coalition, writes in the group's "Breakthroughs" blog, noting, "On [March 1], the Office of Management and Budget released a report to Congress, which details funding cuts required to offset $85 billion in the fiscal year 2013 budget."
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans.
› Verified 3 days ago
| Entity Name | Springfield Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780657783 PECOS PAC ID: 6507760337 Enrollment ID: O20040130000327 |
News Archive
Researchers report that the addition of Achilles tendon lengthening to procedures for managing diabetic forefoot and midfoot ulceration seems warranted.
Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma.
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.
"Although we're several days into sequestration, details about the full impact of funding cuts are still hazy," Kim Lufkin, communications officer of the Global Health Technologies Coalition, writes in the group's "Breakthroughs" blog, noting, "On [March 1], the Office of Management and Budget released a report to Congress, which details funding cuts required to offset $85 billion in the fiscal year 2013 budget."
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans.
› Verified 3 days ago
| Entity Name | Springfield Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033225875 PECOS PAC ID: 6507760337 Enrollment ID: O20040421000503 |
News Archive
Researchers report that the addition of Achilles tendon lengthening to procedures for managing diabetic forefoot and midfoot ulceration seems warranted.
Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma.
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.
"Although we're several days into sequestration, details about the full impact of funding cuts are still hazy," Kim Lufkin, communications officer of the Global Health Technologies Coalition, writes in the group's "Breakthroughs" blog, noting, "On [March 1], the Office of Management and Budget released a report to Congress, which details funding cuts required to offset $85 billion in the fiscal year 2013 budget."
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward Glenn Browning, DO 1108 E Patterson St, Suite 5, Kirksville, MO 63501-4002 Ph: (660) 627-1229 | Dr Edward Glenn Browning, DO 1108 E Patterson St, Suite 5, Kirksville, MO 63501-4002 Ph: (660) 627-1229 |
News Archive
Researchers report that the addition of Achilles tendon lengthening to procedures for managing diabetic forefoot and midfoot ulceration seems warranted.
Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma.
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.
"Although we're several days into sequestration, details about the full impact of funding cuts are still hazy," Kim Lufkin, communications officer of the Global Health Technologies Coalition, writes in the group's "Breakthroughs" blog, noting, "On [March 1], the Office of Management and Budget released a report to Congress, which details funding cuts required to offset $85 billion in the fiscal year 2013 budget."
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans.
› Verified 3 days ago
Dr. John Dee Bailey, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1701 N Elson St, Kirksville, MO 63501 Phone: 660-665-0950 Fax: 660-665-0699 | |
Kevin M Marberry, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 W Jefferson St Fl 1, Kirksville, MO 63501 Phone: 660-626-2663 |